Nevolat: The UK Saxenda Replacement (Patient Information)
Patient information about Nevolat (liraglutide), the generic equivalent of Saxenda in the UK. Not an advertisement and not medical advice.
Important information for UK consumers. Nevolat (liraglutide) is a prescription-only medicine (POM) in the UK. UK regulations restrict the advertising of prescription medicines to the public, so this article is general patient information — it is not an advertisement, not an offer of sale, and not medical advice.
Background
Saxenda (liraglutide 6mg/ml) was discontinued. Nevolat is the generic equivalent that replaced it, with the same active ingredient at the same dose. Both are administered as a daily subcutaneous injection following a stepped dose-escalation schedule under prescriber guidance.
| Aspect | Nevolat | Saxenda (discontinued) |
|---|---|---|
| Active ingredient | Liraglutide 6mg/ml | Liraglutide 6mg/ml |
| Manufacturer | Zentiva | Novo Nordisk |
| Administration | Daily subcutaneous injection | Daily subcutaneous injection |
| Dose schedule | 0.6mg → 1.2mg → 1.8mg → 2.4mg → 3mg | Identical to Nevolat |
| UK status | Available with private or NHS prescription | Discontinued |
What to discuss with a UK prescriber
- Whether Nevolat is clinically appropriate for your circumstances, given other GLP-1 options.
- The dose escalation schedule and tolerability monitoring approach.
- Whether weekly GLP-1 medicines (where licensed) may be more convenient than a daily injection.
For the full Nevolat patient-information page see Nevolat — UK Patient Information.
If you have spotted an error
Please tell us via the corrections route.
Data funnel
Help improve UK healthcare price data
TreatCompare gets more useful when readers send real quotes, providers verify listings, and outdated claims are corrected. Submissions are reviewed before publication.
Frequently asked questions
What is Nevolat?
Nevolat (liraglutide) is a daily injectable prescription-only medicine manufactured by Zentiva. It contains the same active ingredient as the discontinued brand Saxenda, at the same dose, and is the generic equivalent that replaced it in the UK.
Why does this article not show Nevolat prices?
Nevolat is a prescription-only medicine in the UK. UK Human Medicines Regulations 2012 prohibit advertising prescription medicines to the public. TreatCompare does not display UK Nevolat prices.
Continue with UK weight-loss cost guidance
Weight Loss Injection Cost UK
Service-cost framework, NHS eligibility, provider checks and patient information for Mounjaro, Wegovy, Ozempic and Nevolat queries.
Lower-Cost Injection Route
NHS access, service fees and provider checks
Mounjaro Price UK Questions
Service fees, NHS access and provider checks
Wegovy Price UK Questions
Service fees, NHS access and dose context
Mounjaro Patient Information
Tirzepatide doses, safety checks and prescriber questions
Wegovy Patient Information
Semaglutide 2.4mg doses, safety checks and NHS route
Related articles
Who Should Not Take Mounjaro or Wegovy? A GP's Guide
A UK GP's guide to who should not take Mounjaro (tirzepatide) or Wegovy (semaglutide), who needs extra caution, and the red-flag symptoms that need urgent medical help. Patient information, not medical advice.
Lower-Cost Weight Loss Injections UK 2026: NHS Access, Service Fees and Provider Checks
Lower-cost weight loss injections UK guide: how to compare private consultation service fees, NHS eligibility, follow-up costs and provider safety checks without public prescription-medicine price tables.
GLP-1 Weight-Management Medicines in the UK: Patient Information (2026)
Patient information about the GLP-1 receptor agonists used for weight management or type 2 diabetes in the UK — Mounjaro, Wegovy, Ozempic, Rybelsus, Nevolat. No prescription-medicine prices.
How to Get Mounjaro in the UK: Patient Information (2026)
Patient information about UK NHS and private routes for Mounjaro (tirzepatide). Not an advertisement and not medical advice.